Acwin Pharma Private Limited
About Acwin Pharma Private Limited
Data last updated:
Acwin Pharma Private Limited is a private limited company based in Sanand, Gujarat, India. It was incorporated on 29 December 2023.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U46497GJ2023PTC147310.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Rajendra Bhogilal Patel (Non- Individual Subscriber) and Rajkumar Mahendrabhai Shah.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Sanand, Gujarat.
As per the financials filed for FY 2025, the company reported a revenue of ₹41.02 Lakh. For the same year it recorded a net loss of ₹56,860 (net margin -1.4%) and EBITDA of -₹54,040 (EBITDA margin -1.3%).
As per MCA filings, the company has open charges of ₹5 Lakh on record.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address1 Stfloor30Gopi Industrial, Estate B/H Ramdev Masala, Sanand, Gujarat, India – 382213
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Acwin Pharma Private Limited
The main business activity of Acwin Pharma is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Acwin Pharma Private Limited FY 2025 filings available
Acwin Pharma Private Limited reported revenue of ₹41.02 Lakh for FY 2025.
Financial Statement Summary of Acwin Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | -₹54,040 | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | -₹56,860 | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Acwin Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -1.3% | •••• |
| Net Profit Margin | -1.4% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Acwin Pharma are in the company report.
Financial statements from FY 2024
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Acwin Pharma Private Limited
Acwin Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nascent Lifescience Private Limited | ₹41.21 Lakh (FY 2024) | •••• | •••• | -84.0% | •••• | Ahmedabad, Gujarat, India |
| Puritan Pharmaceutical Private Limited | ₹41.18 Lakh (FY 2019) | •••• | •••• | -1.0% | •••• | Patna, Bihar, India |
| Gracemed Formulations Private Limited | ₹41.18 Lakh (FY 2021) | •••• | •••• | -4.0% | •••• | Lucknow, Uttar Pradesh, India |
| Prince Laboratories Private Limited | ₹41.15 Lakh (FY 2024) | •••• | •••• | 12.0% | •••• | Hyderabad, Telangana, India |
| Kshipra Drugs Private Limited | ₹41.03 Lakh (FY 2025) | •••• | •••• | -81.0% | •••• | Dewas, Madhya Pradesh, India |
| Acwin Pharma Private Limited this company | ₹41.02 Lakh (FY 2025) | •••• | •••• | •••• | Sanand, Gujarat, India | |
| A.I.Sure Pharmaceutical Private Limited | ₹40.83 Lakh (FY 2023) | •••• | •••• | 2.0% | •••• | Pune City, Maharashtra, India |
| Durga Medical Foundation (DMF) Private Limited | ₹40.79 Lakh (FY 2021) | •••• | •••• | -30.0% | •••• | Navi Mumbai, Maharashtra, India |
| Helen Pharmaceuticals Private Limited | ₹40.78 Lakh (FY 2024) | •••• | •••• | •••• | Rangareddy, Telangana, India | |
| Signavox Technologies Private Limited | ₹40.73 Lakh (FY 2024) | •••• | •••• | -49.0% | •••• | Shaikpet, Telangana, India |
| Zelkova Lifesciences Private Limited | ₹40.69 Lakh (FY 2025) | •••• | •••• | 21.0% | •••• | Bhopal, Madhya Pradesh, India |
Peers are the five companies nearest above and the five nearest below Acwin Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Acwin Pharma Private Limited
Acwin Pharma has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajendra Bhogilal Patel | Non- Individual Subscriber | 29 Dec 2023 | 2 Years 9 Months | Current |
| Rajkumar Mahendrabhai Shah Also directs: Aurocare Lifesciences Private Limited | Director | 29 Dec 2023 | 2 Years 9 Months | Current |
| Daksha Rajendra Patel | Director | 29 Dec 2023 | 2 Years 9 Months | Current |
Charges & Borrowings of Acwin Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Nov 2025 | Others | ₹5 Lakh | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Acwin Pharma Private Limited
Employment history and EPFO contributions of people linked to Acwin Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Acwin Pharma Private Limited
Acwin Pharma Private Limited has 3 board changes on record since 2023: 3 appointments. The latest: Daksha Rajendra Patel was appointed as Director on 29 Dec 2023.
Credit Ratings, Litigation & Regulatory Alerts for Acwin Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Acwin Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Acwin Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Acwin Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Acwin Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Acwin Pharma Private Limited
Acwin Pharma is an active private limited company based in Sanand, Gujarat, India. It was incorporated on 29 December 2023 (3+ years old) and is registered under CIN U46497GJ2023PTC147310.
Acwin Pharma reported revenue of ₹41.02 Lakh for FY 2025.
Acwin Pharma has 3 current directors:
- Rajkumar Mahendrabhai Shah - Director
- Daksha Rajendra Patel - Director
- Rajendra Bhogilal Patel - Non- Individual Subscriber
Acwin Pharma reported a net loss of ₹56,860 (net margin -1.4%) and EBITDA of -₹54,040 (EBITDA margin -1.3%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Acwin Pharma is U46497GJ2023PTC147310. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Acwin Pharma was incorporated on 29 December 2023, making it 3+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Acwin Pharma by revenue are Nascent Lifescience Private Limited, Puritan Pharmaceutical Private Limited, Gracemed Formulations Private Limited, Prince Laboratories Private Limited, Kshipra Drugs Private Limited and 5 more, all in the Pharma industry (Formulations).
Daksha Rajendra Patel was appointed as Director on 29 Dec 2023. Rajendra Bhogilal Patel was appointed as Non- Individual Subscriber on 29 Dec 2023. Rajkumar Mahendrabhai Shah was appointed as Director on 29 Dec 2023.
The registered office of Acwin Pharma is at 1 Stfloor30Gopi Industrial, Estate BH Ramdev Masala, Sanand, Gujarat, India – 382213.
Acwin Pharma has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.
No. Acwin Pharma is not listed on any stock exchange. It is an unlisted company.